None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Full term neonates or infants aged 0-2 months 2 Neonates delivered via Normal vaginal delivery or caesarean section (LSCS) 3 Full term neonates or infants of either sex 4 Informed consent obtained through parents 5 Birth weight of neonates more than 2kgs
Exclusion criteria
Exclusion criteria: 1 Preterm Infants 2 History of birth asphyxia, neonates with pathological jaundice 3 Congenital anomalies and genetic defects 4 All systemic disorders 5 Syndromic babies 6 Infants with NICU admission
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the health status of neonates through infant health related quality of life instruments after co administration of Swarnaprashna with conventional immunization in infants of 0 to 2 monthsTimepoint: 0th day, 2nd week, 4th week, 6th week | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 To evaluate the impact of Swarnaprashna when co administered with conventional immunization in infants of 0 to 2 months through IL-1 expression 2 To evaluate ADR as per AYUSH Suraksha reporting format to pharmacovigilance department of institution during drug administration.Timepoint: 6th week | — |
Countries
India
Contacts
SDM College of Ayurveda, Hospital and Research Centre, Kuthpady, Udupi, Karnataka